secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bausch & Lomb Corp (BLCO)
CIK:        0001860742
Form:       8-K
Filed at:   2023-09-14T23:59:59+00:00
Accession:  0001193125-23-235410
Event type: debt
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bausch + Lomb prices $1.4B 8.375% senior secured notes due 2028 for XIIDRA acquisition financing
--------------------------------------------------------------------------------

- Priced $1.4B aggregate principal of 8.375% senior secured notes due 2028 at par; closing expected Sept 29, 2023.
- Also plans $500M incremental term B loans under existing credit facility; drawn upon acquisition close.
- Net proceeds to fund pending acquisition of XIIDRA (lifitegrast ophthalmic solution) and other ophthalmology assets.
- If notes issued before acquisition close, proceeds held in escrow by Bausch + Lomb Escrow Corp.; B+L assumes after close.
- If acquisition not closed by Sept 30, 2024, Escrow Issuer must redeem notes at principal plus accrued interest.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1860742/000119312523235410/0001193125-23-235410-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1860742/000119312523235410/d507757d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-235410

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer